OBJECTIVE: To investigate the application of Danhong injection in inpatient prescriptions of the hospital

and to provide reference for clinical medication

so as to improve the quality of prescription and safety and effectiveness of medication. METHODS: From Jan. 2018 to Feb. 2022

68 211 inpatient prescriptions of Danhong injection were extracted from the information system of the hospital. The prescription analysis system PA 2.1 independently developed by the hospital was used to perform special review on basic prescription information

clinical diagnosis and drug combination. RESULTS: Of the 68 211 prescriptions of Danhong injection

there were 3 038 inappropriate prescriptions（4.45%）

mainly for repeated medication prescriptions（3 018 prescriptions

4.42%） and incompatible prescriptions（20 prescriptions

0.03%）. There were 5 097 potential risk prescriptions（7.47%）

mainly reflected in potential drug interactions. CONCLUSIONS: The application of Danhong injection in the hospital is basically reasonable

yet the problems such as repeated medication and incompatibility should be prevented. Meanwhile

attention should be paid to the pharmaceutical care when Danhong injection is used in combination with high-risk drugs to promote rational drug use.